PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION

The present invention provides a pharmaceutical composition containing, as an active ingredient, a dihydropyridazine-3,5-dione derivative or a salt thereof or a solvate of these, wherein the composition is administered in combination with a phosphorus adsorbent.

Saved in:
Bibliographic Details
Main Authors IDE, Mitsuaki, ONO, Yoshiyuki, KIMBARA, Atsushi, ICHIDA, Yasuhiro, OHTAKE, Yoshihito, TACHIBANA, Kazutaka, TANAKA, Shota, HORIBA, Naoshi, KASHIWAGI, Hirotaka, MIZUGUCHI, Eisaku, NOMURA, Kenichi, HORI, Nobuyuki, OHTOMO, Shuichi, HARADA, Takeo, OKAMOTO, Naoki, MURATA, Yoshihisa
Format Patent
LanguageEnglish
French
German
Published 06.03.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a pharmaceutical composition containing, as an active ingredient, a dihydropyridazine-3,5-dione derivative or a salt thereof or a solvate of these, wherein the composition is administered in combination with a phosphorus adsorbent.
Bibliography:Application Number: EP20210185137